-
CAS号：828247-64-9|Amlodipine besylate, (R)-
作者：德尔塔 日期：2022-12-23
中文别名：Amlodipine besylate, (R)-英文别名：Amlodipine besylate, (R)-CAS号：828247-64-9SMILES：CCOC(=O)C1=C(NC(=C([C@H]1c2ccccc2Cl)C(=O)OC)C)COCCN.c1ccc(cc1)S(=O)(=O)OInchi：1S/C20H25ClN2O5.C6H6O3S/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;7-10(8,9)6-4-2-1-3-5-6/h5-8,17,23H,4,9-11,22H2,1-3H3;1-5H,(H,7,8,9)/t17-;/m1./s1InchiKey：ZPBWCRDSRKPIDG-UNTBIKODSA-N分子式 Formula：C26H31ClN2O8S分子量 Molecular Weight：567.05闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Amlodipine besylate, (R)-(CAS:828247-64-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionAmlodipine besylate, (R)- is a medication used to lower blood pressure and prevent chest pain. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Gottwald-Hostalek U, Sun N, Barho C, Hildemann S. Management of Hypertension With a Fixed-Dose (Single-Pill) Combination of Bisoprolol and Amlodipine. Clin Pharmacol Drug Dev. 2017 Jan;6(1):9-18. doi: 10.1002/cpdd.309. Epub 2016 Oct 26. PubMed PMID: 27653022.[2]van Zwieten PA. Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. Clin Cardiol. 1994 Sep;17(9 Suppl 3):III3-6. Review. PubMed PMID: 9156957.订购说明：1、绝大部分产品备有现货，一般情况下都能订货当日发货。2、部
-
CAS号：1330781-04-8|Cdc7-IN-7c
作者：德尔塔 日期：2022-12-23
中文别名：Cdc7-IN-7c英文别名：Cdc7-IN-7c; Cdc7 IN 7c; Cdc7IN7c; Cdc7 inhibitor 7c; Cdc7 inhibitor-7c;CAS号：1330781-04-8SMILES：O=C1C2=C(C=C(C3=CNN=C3C)S2)N=C(CN4CCCC4)N1Inchi：InChI=1S/C15H17N5OS/c1-9-10(7-16-19-9)12-6-11-14(22-12)15(21)18-13(17-11)8-20-4-2-3-5-20/h6-7H,2-5,8H2,1H3,(H,16,19)(H,17,18,21)InchiKey：MUYIKPWUBQUQAV-UHFFFAOYSA-N分子式 Formula：C15H17N5OS分子量 Molecular Weight：315.39闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cdc7-IN-7c(CAS:1330781-04-8):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCdc7-IN-7c is a highly potent, selective and time-dependent Cdc7 kinase inhibitor. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Kurasawa O, Homma M, Oguro Y, Miyazaki T, Mori K, Uchiyama N, Iwai K, Ohashi A, Hara H, Yoshida S, Cho N. 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorg Med Chem. 2017 Jul 15;25(14):3658-3670. doi: 10.1016/j.bmc.2017.04.044. Epub 2017 May 2. PubMed PMID: 28533114.订购说明：1、绝大部分产品备有现货，一般情况下都能订货当日发货。2、部分非常用产品，需提前1－2日预订，海外期货则需要提前3-6周预订。3、部分产品价格会因货期、批次等因素发生变化，若有变动以订货当日新价
-
CAS号：162542-90-7|CDP840 HCl
作者：德尔塔 日期：2022-12-23
中文别名：CDP840 HCl英文别名：CDP840; CDP-840; CDP 840; CDP840 HCl; CDP840HCl.CAS号：162542-90-7SMILES：COC1=CC=C([C@@H](C2=CC=CC=C2)CC3=CC=NC=C3)C=C1OC4CCCC4.[H]ClInchi：InChI=1S/C25H27NO2.ClH/c1-27-24-12-11-21(18-25(24)28-22-9-5-6-10-22)23(20-7-3-2-4-8-20)17-19-13-15-26-16-14-19;/h2-4,7-8,11-16,18,22-23H,5-6,9-10,17H2,1H3;1H/t23-;/m1./s1InchiKey：DQXFOLCDYKWSIT-GNAFDRTKSA-N分子式 Formula：C25H28ClNO2分子量 Molecular Weight：409.95闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明CDP840 HCl(CAS:162542-90-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCDP840 HCl is a potent and selective inhibitor of phosphodiesterase (PDE) 4 (IC50 = 12 nM for native PDE4). CDP840 HCl competitively inhibits all PDE4 isoenzymes. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Muraoka N, Mineno M, Itami K, Yoshida J. Rapid synthesis of CDP840 with 2-pyrimidyl vinyl sulfide as a platform. J Org Chem. 2005 Aug 19;70(17):6933-6. PubMed PMID: 16095319.[2]Alexander RP, Warrellow GJ, Eaton MA, Boyd EC, Head JC, Porter JR, Brown JA, Reuberson JT, Hutchinson B, Turner P, Boyce B, Barnes D, Mason B, Cannell A, Taylor RJ, Zomaya A, Millican A, Leonard J, Morphy R, Wales M, Perry M, Allen RA, Gozzard N, Hughes B, Higgs G. CDP840. A prototype of a no
-
CAS号：870615-40-0|CE-326597
作者：德尔塔 日期：2022-12-23
中文别名：CE-326597英文别名：CE-326597; CE326597; CE 326597.CAS号：870615-40-0SMILES：CC(C)N(C(CN(C1=O)C2=CC=CC=C2N3C(C4=CC=CC=C4)=NN=C3[C@@H]1CC5=CNC6=C5C=CC=C6)=O)CC7=CC=CC=C7Inchi：InChI=1S/C37H34N6O2/c1-25(2)41(23-26-13-5-3-6-14-26)34(44)24-42-32-19-11-12-20-33(32)43-35(27-15-7-4-8-16-27)39-40-36(43)30(37(42)45)21-28-22-38-31-18-10-9-17-29(28)31/h3-20,22,25,30,38H,21,23-24H2,1-2H3/t30-/m0/s1InchiKey：UBNMGTSDHSQBEL-PMERELPUSA-N分子式 Formula：C37H34N6O2分子量 Molecular Weight：594.719闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明CE-326597(CAS:870615-40-0):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCE-326597 is a potent and selective CCK1R agonist. The type 1 cholecystokinin receptor (CCK1R) has multiple physiologic roles relating to nutrient homeostasis,including mediation of postcibal satiety. The type 1 cholecystokinin (CCK) receptor (CCK1R) is a key mediator of postcibal satiety and a potential target for drugs that may be useful to prevent and/or treat obesity. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：Aditya J. Desai, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Arthur Christopoulos, Patrick M. Sexton, and Laurence J. Miller. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type
-
CAS号：53950-14-4|Cefalexin lysine
作者：德尔塔 日期：2022-12-23
中文别名：Cefalexin lysine英文别名：Cefalexin lysine;CAS号：53950-14-4SMILES：N[C@@H](CCCCN)C(O)=O.O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC(C(N)C3=CC=CC=C3)=O)C1=O)OInchi：InChI=1S/C16H17N3O4S.C6H14N2O2/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9;7-4-2-1-3-5(8)6(9)10/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23);5H,1-4,7-8H2,(H,9,10)/t10?,11-,15-;5-/m10/s1InchiKey：CSXICSKZWGBACI-ZMZYGIGZSA-N分子式 Formula：C22H31N5O6S分子量 Molecular Weight：493.57闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cefalexin lysine(CAS:53950-14-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCefalexin lysine is a derivative of Cefalexin, an antibiotic. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Cadórniga R, Barrios S, Segura J, Roberts DJ. Penetration of antibiotic into interstitial tissue fluid following parenteral administration of lysine cephalexin. Arzneimittelforschung. 1979;29(10):1547-9. PubMed PMID: 583220.[2]Barrios S, Sorensen JH, Spickett RG. Bioavailability of cephalexin after intramuscular injection of its lysine salt. J Pharm Pharmacol. 1975 Sep;27(9):711-2. PubMed PMID: 241820.[3] Kale SN, Jadhav AD, Verma S, Koppikar SJ, Kaul-Ghanekar R, Dhole SD, Ogale SB. Characterization of biocompatible NiCo2O
-
CAS号：51627-20-4|Cefaparole
作者：德尔塔 日期：2022-12-23
中文别名：Cefaparole英文别名：Cefaparole; Lilly 110264; Lilly-110264; Lilly110264; 110264; Cefaparolum; Cefaparol;CAS号：51627-20-4SMILES：O=C(C(N12)=C(CSC3=NN=C(C)S3)CS[C@]2([H])[C@H](NC(C(N)C4=CC=C(O)C=C4)=O)C1=O)OInchi：InChI=1S/C19H19N5O5S3/c1-8-22-23-19(32-8)31-7-10-6-30-17-13(16(27)24(17)14(10)18(28)29)21-15(26)12(20)9-2-4-11(25)5-3-9/h2-5,12-13,17,25H,6-7,20H2,1H3,(H,21,26)(H,28,29)/t12?,13-,17-/m1/s1InchiKey：SBUCDZYLTRYMFG-QQGYXAEISA-N分子式 Formula：C19H19N5O5S3分子量 Molecular Weight：493.57闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cefaparole(CAS:51627-20-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCefaparole is an antibacterial agent and cell wall biosynthesis inhibitor. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注。订购说明：1、绝大部分产品备有现货，一般情况下都能订货当日发货。2、部分非常用产品，需提前1－2日预订，海外期货则需要提前3-6周预订。3、部分产品价格会因货期、批次等因素发生变化，若有变动以订货当日新价格为准。4、每日订单截止时间为16点整，部分城市可到17点整，因超过截止时间造成当日不能发货的将于次日安排发货。运输说明：极低温产品：极低温产品运输过程中加装干冰运输。用干冰把产品包裹起来，再用泡沫盒密封，胶带层层粘住泡沫盒，放入德尔塔生物的箱子，然后交付给合作快递，安全快速高效放心的送至客户的手中
-
CAS号：724438-16-8|Cefetamet Hydrochloride
作者：德尔塔 日期：2022-12-23
中文别名：Cefetamet Hydrochloride英文别名：Cefetamet Hydrochloride; Cefetamet HCl; CefetametCAS号：724438-16-8SMILES：O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O.ClInchi：InChI=1S/C14H15N5O5S2.ClH/c1-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24-2)6-4-26-14(15)16-6;/h4,8,12H,3H2,1-2H3,(H2,15,16)(H,17,20)(H,22,23);1H/b18-7-;/t8-,12-;/m1./s1InchiKey：KILIJEXWGYQTDT-KYIYMPJCSA-N分子式 Formula：C14H16ClN5O5S2分子量 Molecular Weight：433.882闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cefetamet Hydrochloride(CAS:724438-16-8):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCefetamet Hydrochloride is a cephalosporin antibiotic potentially for the treatment of bacterial infections. Cefetamet is a potent antibiotic to treat respiratory and urinary tract infections. To improve oral bioavailability, it is administered as a prodrug, cefetamet pivoxyl hydrolyzed by esterase following absorption. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Garbacki P, Cielecka-Piontek J, Zalewski P, Oszczapowicz I, Jelińska A. A SIMPLE AND-SENSITIVE STABILITY-INDICATING UHPLC-DAD METHOD FOR THE DETERMINATION OF CEFETAMET PIVOXIL HYDROCHLORIDE. Acta Pol Pharm. 2016 May-Jun;73(3):621-6. PubMed PMID: 27476279.[2]Wa
-
CAS号：140128-74-1|Cefmatilen
作者：德尔塔 日期：2022-12-23
中文别名：Cefmatilen英文别名：Cefmatilen; S 1090; S-1090; S1090;CAS号：140128-74-1SMILES：O=C(C(N12)=C(SCSC3=CNN=N3)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\O)=O)C1=O)OInchi：InChI=1S/C15H14N8O5S4/c16-15-18-5(2-30-15)8(21-28)11(24)19-9-12(25)23-10(14(26)27)6(3-29-13(9)23)31-4-32-7-1-17-22-20-7/h1-2,9,13,28H,3-4H2,(H2,16,18)(H,19,24)(H,26,27)(H,17,20,22)/b21-8-/t9-,13-/m1/s1InchiKey：UEQVTKSAEXANEZ-YCRCPZNHSA-N分子式 Formula：C15H14N8O5S4分子量 Molecular Weight：514.56闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cefmatilen(CAS:140128-74-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCefmatilen is a compound being developed as a cephalosporin antibiotic for oral use. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Takeuchi M, Harada M, Nagata M, Watanabe A, Nakamura K. [Immunological properties of S-1090, cefmatilen hydrochloride hydrate]. J Toxicol Sci. 2001 May;26 Suppl 1:231-42. Japanese. PubMed PMID: 11400315.[2]Yahara I, Furukawa H, Sato K, Nishimura K, Harihara A, Yabuuchi K, Miyauchi H, Kii Y, Muraoka Y, Kitamura T, Kato I. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (1)--Single oral and intravenous dose toxicity studies in rats]. J Toxicol Sci. 2001 May;26 Suppl 1:1-4. Japanese. PubMed PMID: 1
-
CAS号：63767-79-3|Ceforanide lysine
作者：德尔塔 日期：2022-12-23
中文别名：Ceforanide lysine英文别名：Ceforanide lysine; Ceforanide L-lysine salt; BL-S 786 L-Lysine salt; Ceforanide L-lysine;CAS号：63767-79-3SMILES：N[C@@H](CCCCN)C(O)=O.O=C(C(N12)=C(CSC3=NN=NN3CC(O)=O)CS[C@]2([H])[C@H](NC(CC4=CC=CC=C4CN)=O)C1=O)OInchi：InChI=1S/C20H21N7O6S2.C6H14N2O2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30;7-4-2-1-3-5(8)6(9)10/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33);5H,1-4,7-8H2,(H,9,10)/t15-,18-;5-/m10/s1InchiKey：CCMQVCAVLNYLPS-BRQOISLDSA-N分子式 Formula：C26H35N9O8S2分子量 Molecular Weight：665.74闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Ceforanide lysine(CAS:63767-79-3):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCeforanide lysine is an Anti-Infective Agent. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Issopoulos PB. Spectrophotometric determination of certain cephalosporins using molybdophosphoric acid. Part II. Determination of cefadroxil, cefapirin, ceforanide and cefuroxime. Analyst. 1989 Feb;114(2):237-9. PubMed PMID: 2712321.[2]Pfeffer M, Gaver RC, Van Harken DR. Human pharmacokinetics of a new braod-spectrum parenteral cephalosporin antibiotic, ceforanide. J Pharm Sci. 1980 Apr;69(4):398-403. PubMed PM
-
CAS号：121123-17-9|Cefprozil hydrate
作者：德尔塔 日期：2022-12-23
中文别名：Cefprozil hydrate英文别名：Cefprozil hydrate;CAS号：121123-17-9SMILES：O=C(C(N12)=C(/C=C/C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O.[H]O[H]Inchi：InChI=1S/C18H19N3O5S.H2O/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9;/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26);1H2/b3-2+;/t12-,13-,17-;/m1./s1InchiKey：ALYUMNAHLSSTOU-CIRGZYLNSA-N分子式 Formula：C18H21N3O6S分子量 Molecular Weight：407.44闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Cefprozil hydrate(CAS:121123-17-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCefprozil hydrate is a broad-spectrum cephalosporin antibiotic. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Jerath N, Shetty G. Redefining the management of pediatric tonsillopharyngitis with cefprozil. Indian J Pediatr. 2007 Dec;74(12):1105-8. Review. PubMed PMID: 18174646.[2]Anzueto A, Bishai WR, Pottumarthy S. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):31S-38S. Review. PubMed PMID: 17349461.[3] Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):13
-
CAS号：401925-43-7|Celivarone
作者：德尔塔 日期：2022-12-23
中文别名：Celivarone英文别名：CelivaroneCAS号：401925-43-7SMILES：O=C(C1=CC=C(OC(CCCC)=C2C(C3=CC=C(CCCN(CCCC)CCCC)C=C3)=O)C2=C1)OC(C)CInchi：InChI=1S/C34H47NO4/c1-6-9-14-31-32(29-24-28(19-20-30(29)39-31)34(37)38-25(4)5)33(36)27-17-15-26(16-18-27)13-12-23-35(21-10-7-2)22-11-8-3/h15-20,24-25H,6-14,21-23H2,1-5H3InchiKey：ZCENNVQCOZQSGH-UHFFFAOYSA-N分子式 Formula：C34H47NO4分子量 Molecular Weight：533.753闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Celivarone(CAS:401925-43-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionCelivarone is an antiarrhythmic agent. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter. J Cardiovasc Electrophysiol. 2012 May;23(5):462-72. doi: 10.1111/j.1540-8167.2011.02234.x. Epub 2011 Dec 15. PubMed PMID: 22171925.[2]Gojkovic O, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Singh BN, Kowey PR. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-de
-
CAS号：49564-56-9|Fazadinium bromide
作者：德尔塔 日期：2022-12-23
中文别名：Fazadinium bromide英文别名：Fazadinium bromide;CAS号：49564-56-9SMILES：CC1=C(C2=CC=CC=C2)N(/N=N/N3C(C4=CC=CC=C4)=C(C)[N+]5=CC=CC=C53)C6=CC=CC=[N+]61.[Br-].[Br-]Inchi：InChI=1S/C28H24N6.2BrH/c1-21-27(23-13-5-3-6-14-23)33(25-17-9-11-19-31(21)25)29-30-34-26-18-10-12-20-32(26)22(2)28(34)24-15-7-4-8-16-24;;/h3-20H,1-2H3;2*1H/q+2;;/p-2/b30-29+;;InchiKey：LBOZSXSPRGACHC-NFOZGECASA-L分子式 Formula：C28H24Br2N6分子量 Molecular Weight：604.35闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Fazadinium bromide(CAS:49564-56-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionFazadinium bromide is a muscle relaxant which acts as a nicotinic acetylcholine receptor antagonist through neuromuscular blockade. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Esener Z. A clinical study on vecuronium in children: a comparison with fazadinium and pancuronium. Turk J Pediatr. 1988 Jul-Sep;30(3):163-72. PubMed PMID: 2907392.[2]Alvarez Gómez JA, Brugger AJ, Pérez Guillermo F, Lozano Tonkin E, Martínez Pretel C, Gil Sánchez JC. [Electromyographic study of the effects of vecuronium bromide compared with those of pancuronium, tubocurarine, fazadinium and suxamethonium]. Rev Esp Anestesiol Reanim. 1987 Jul-Aug;34(4):237-46. Spanish. PubMed PM
-
CAS号：77257-33-1|Fe-Cap folic
作者：德尔塔 日期：2022-12-23
中文别名：Fe-Cap folic英文别名：Fe-Cap folic;CAS号：77257-33-1SMILES：O=C(c1ccc(NCc(n2)cnc3c2c(nc(N)[nH]3)=O)cc1)N[C@@H](CCC(O)=O)C(O)=O.NCC([O-])=O.[O-]S([O-])(=O)=O.[Fe+2]Inchi：1S/C19H19N7O6.C2H5NO2.Fe.H2O4S/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28;3-1-2(4)5;;1-5(2,3)4/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30);1,3H2,(H,4,5);;(H2,1,2,3,4)/q;;+2;/p-2/t12-;;;/m0.../s1InchiKey：TWIIEENJROOKEF-JNQXMBDASA-L分子式 Formula：C21H23FeN8O12S分子量 Molecular Weight：667.36闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明Fe-Cap folic(CAS:77257-33-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionFe-Cap folic is an encapsulated dosage form containing chelated iron (ferrous glycine sulfate equiv to 80 mg ferrous iron), & 350 mcg folic acid for use as iron supplement in pregnancy. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Shen DW, Su A, Liang XJ, Pai-Panandiker A, Gottesman MM. Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells. Br J Cancer. 2004 Jul 19;91(2):270-6. PubMed PMID: 15199393; PubMed Central PMCID: PMC2409801.订购说明：1、绝大部分产品备有现货，一般情况下都能订货当日发
-
CAS号：1359963-68-0|FEMA4774
作者：德尔塔 日期：2022-12-23
中文别名：FEMA4774英文别名：FEMA4774; FEMA-4774; FEMA 4774; S9632; S-9632; S 9632;CAS号：1359963-68-0SMILES：O=C(C1=C(N)C2=C(OCC(C)(C)C(NC(C)C)=O)C=CC=C2N=C1C)OInchi：InChI=1S/C19H25N3O4/c1-10(2)21-18(25)19(4,5)9-26-13-8-6-7-12-15(13)16(20)14(17(23)24)11(3)22-12/h6-8,10H,9H2,1-5H3,(H2,20,22)(H,21,25)(H,23,24)InchiKey：RHXLOOCFQPJWBW-UHFFFAOYSA-N分子式 Formula：C19H25N3O4分子量 Molecular Weight：359.426闪点 FP：熔点 Melting point：沸点 Boiling point：Polarizability极化度：密度 Density：蒸汽压 Vapor Pressure：溶解度Solubility：性状：Solid powder储藏条件 Storage conditions：Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).产品说明FEMA4774(CAS:1359963-68-0):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。 IntroductionFEMA4774, also known as S9632, is the novel T1R2/T1R3 positive allosteric modulator. FEMA4774 shows obvious enhancement of the sweetness of sucrose in sensory evaluation tests. Application1Application2 Application3危险性：Warning危险性警示：安全声明：安全防护：备注：[1]Arthur AJ, Karanewsky DS, Liu H, Chi B, Markison S. Toxicological evaluationof the flavour ingredient4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid. Toxicol Rep. 2015 Sep 3;2:1255-1264. doi:10.1016/j.toxrep.2015.08.012. eCollection 2015. PubMed PMID: 28962468; PubMedCentral PMCID: PMC5598146.订购说明：1、绝大部分产品备有现货，一般情况下都能订货当日发货。2、部分非常用产品，需提前1－2日预订，海外期货则需要提前3-6周预订。3、部分产品价格会因
-
CAS号：60-45-7|4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione
作者：德尔塔 日期：2022-12-23
中文别名：4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione:(60-45-7)英文别名：4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione:(60-45-7)CAS号：60-45-7SMILES：CCC1C(=O)NC(=O)C1(C)C2=CC=CC=C2Inchi：InChI=1S/C13H15NO2/c1-3-10-11(15)14-12(16)13(10,2)9-7-5-4-6-8-9/h4-8,10H,3H2,1-2H3,(H,14,15,16)InchiKey：WYOMHOATUARGQV-UHFFFAOYSA-N分子式 Formula：C13H15NO2分子量 Molecular Weight：217闪点 FP：155.9±25.0 °C熔点 Melting point：No date available沸点 Boiling point：382.2±31.0 °C at 760 mmHgPolarizability极化度：24.0±0.5 10-24cm3密度 Density：1.1±0.1 g/cm3蒸汽压 Vapor Pressure：0.0±0.9 mmHg at 25°C溶解度Solubility：性状：No date available储藏条件 Storage conditions：storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)实验注意事项：1.实验前需戴好防护眼镜，穿戴防护服和口罩，佩戴手套，避免与皮肤接触。2.实验过程中如遇到有毒或者刺激性物质及有害物质产生，必要时实验操作需要手套箱内完成以免对实验人员造成伤害3.实验后产生的废弃物需分类存储，并交于专业生物废气物处理公司处理，以免造成环境污染Experimental considerations: 1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment. 2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.产品说明4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione:(60-45-7)用于科学研究及合成中间体,60-45-7其他参数见主页 Introduction4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione:(60-45-7)Used in scientific research and synthetic intermediates,60-45-7 See homepage for other param
咨询热线
18133906270
德尔塔官方微信